Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Arthur Baghdanian

Diagnostic Radiology Los Angeles, CA Medical Doctor

NPI 1902168826 CMS profile 3496945

1500 San Pablo St Fl 2, Los Angeles, CA 90033

Open in the dashboard

General payments

$219,413

78 records reported · program years 2021–2025

Research payments

$126,427

Paid to them · 56 records reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$425,143 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Arthur Baghdanian of Los Angeles, CA is reported in the CMS Open Payments database as having received $219,413 across 78 general payments and $126,427 in research payments paid to them. Separately, studies naming them as principal investigator received $425,143 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 Research $68,005 13
2024 Research $15,810 11
2023 General $64,263 26
2023 Research $5,448 9
2022 General $49,545 21
2022 Research $5,685 11
2021 General $105,606 31
2021 Research $31,480 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Arthur Baghdanian
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Arthur Baghdanian were reported at $0. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Arthur Baghdanian Diagnostic Radiology median Middle half National median
2019 $0 $108 $29–$318 $163
2020 $0 $65 $21–$252 $114
2021 $105,606 $92 $24–$292 $132
2022 $49,545 $104 $29–$294 $149
2023 $64,263 $110 $29–$337 $160
2024 $0 $113 $30–$356 $164
2025 $0 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Merck Sharp & Dohme Corporation $101,748 27 payments
  2. BioNTech SE $61,430 23 payments
  3. Boehringer Ingelheim RCV GmbH & Co KG $49,030 25 payments
  4. Siemens Medical Solutions USA, Inc. $7,178 2 payments
  5. Novartis Pharmaceuticals Corporation $28 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $219,386 77 payments
  2. Food and Beverage $28 1 payment
Products named General payments · program years 2021–2025
  1. KEYTRUDA $97,143 16 payments
  2. WELIREG $650 4 payments
  3. LENVIMA $350 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2021–2025
  1. GlaxoSmithKline, LLC. $72,110 10 payments
  2. Regeneron Pharmaceuticals, Inc. $54,318 46 payments

Billing to Medicare

Part B · data year 2024 · 12 billing codes

Paid by Medicare

$21,712

Medicare's payments for the services billed

Medicare patients

209

Average age 72

Services billed

314

109 women, 100 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Cancer 56%
Arthritis 44%
Diabetes 39%
Ischemic heart disease 33%
Chronic kidney disease 31%
Depression 22%
Osteoporosis 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

134 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record